glp-1 and chronic kidney disease Repurposing Diabetes Therapies in CKD: Mechanistic Insights, Clinical Outcomes Safety of SGLT2i and RAs GLP-1 and the kidney: from

GCLC knockout mice die within a month of birth due to the absence of hepatic GSH synthesis

It is important to note that claims about increased energy expenditure in humans remain insufficiently evidenced at this stage, and the net glycaemic effects reflect observed trial outcomes rather than a straightforward mechanistic reduction in hepatic glucose output the concurrent glucagon receptor agonism may, in fact, influence hepatic glucose production in a complex and not fully characterised manner

Both add important information to ongoing melanocortin receptor and synthetic peptide research

2 Since it is non-peptide, orforglipron avoids GI degradation barriers that limit peptides, thereby enabling once-daily administration while maintaining efficacy on glucose control, body weight, and tolerability

271,278 Alcohol intake has been correlated with an increased risk of bothersome early-onset hot flashes, 284 and some research suggests increased caffeine consumption may be associated with a small increase in menopausal hot flash scores